Partnership
UNC Chapel Hill x GSK HIV Cure Research Partnership
UNC Chapel Hill and GlaxoSmithKline established a partnership to create a dedicated HIV cure research center on campus and a jointly owned company called Qura Therapeutics. The collaboration focuses on scientific approaches to curing HIV including novel therapeutic strategies.
development · Active · operating
Machine-readable surfaces
- Markdown mirror: /partnerships/unc-chapel-hill-x-gsk-hiv-cure-research-partnership.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/partnerships/unc-chapel-hill-x-gsk-hiv-cure-research-partnership
- Revision history: /partnerships/unc-chapel-hill-x-gsk-hiv-cure-research-partnership/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
20422c86-7d89-4455-8473-1db62e7177ee- Type
- development
- Status
- Activeoperating
Who’s involved
University of North Carolina at Chapel Hillco developer
Public research university in Chapel Hill, North Carolina, chartered in 1789. It began enrolling students in 1795, making it one of the oldest public universities in the United States.
Off-registry parties
- GlaxoSmithKline · co developer
Related partnerships
Other deals between the same parties
- UNC Chapel Hill x SAS Antiviral Drug Development PartnershipUniversity of North Carolina at Chapel Hill + SAS Institutedevelopment—operating
Other partnerships of University of North Carolina at Chapel Hill
- UNC Chapel Hill x SAS Antiviral Drug Development PartnershipUniversity of North Carolina at Chapel Hill + SAS Institutedevelopment—operating
Recent partnerships of the same kind
- Canvas x USG CorporationCanvas + USG Corporationdevelopment—operating
- development—operating
- Kautex Textron RESiLiTE Horizon EuropeKautex Textron + Horizon Europe EU Programmedevelopment—operating
- RIKEN BDR x Otsuka Pharmaceutical CollaborationRIKEN Center for Biosystems Dynamics + Otsuka Pharmaceuticaldevelopment—operating
- Entegris x SEMATECHEntegris + SEMATECHdevelopment—operating
- development—operating
Sources (1)
Deploy Watch
Track this partnership.
We notify you when the status changes against primary-source evidence, expansion is verified, or the partnership is terminated.